Advertisement

Index by author

March 01, 2019; Volume 95,Issue 3

A

  1. Abagyan, Ruben

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

  2. Abbott, Kodye L.

    1. Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression
      Kodye L. Abbott, Chloe S. Chaudhury, Aneesh Chandran, Saraswathi Vishveshwara, Zdenek Dvorak, Eva Jiskrova, Karolina Poulikova, Barbora Vyhlidalova, Sridhar Mani and Satyanarayana R. Pondugula
      Molecular Pharmacology March 2019, 95 (3) 324-334; DOI: https://doi.org/10.1124/mol.118.114587

  3. Antoine, Mathias

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

B

  1. Bertrand, Marc

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  2. Bhat, Shreyas

    1. Open Access
      Functional Selectivity and Partial Efficacy at the Monoamine Transporters: A Unified Model of Allosteric Modulation and Amphetamine-Induced Substrate Release
      Peter S. Hasenhuetl, Shreyas Bhat, Michael Freissmuth and Walter Sandtner
      Molecular Pharmacology March 2019, 95 (3) 303-312; DOI: https://doi.org/10.1124/mol.118.114793

  3. Bouillaud, Frederic

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  4. Boutin, Jean A.

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  5. Brebner, Karen

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

C

  1. Chandran, Aneesh

    1. Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression
      Kodye L. Abbott, Chloe S. Chaudhury, Aneesh Chandran, Saraswathi Vishveshwara, Zdenek Dvorak, Eva Jiskrova, Karolina Poulikova, Barbora Vyhlidalova, Sridhar Mani and Satyanarayana R. Pondugula
      Molecular Pharmacology March 2019, 95 (3) 324-334; DOI: https://doi.org/10.1124/mol.118.114587

  2. Chaudhury, Chloe S.

    1. Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression
      Kodye L. Abbott, Chloe S. Chaudhury, Aneesh Chandran, Saraswathi Vishveshwara, Zdenek Dvorak, Eva Jiskrova, Karolina Poulikova, Barbora Vyhlidalova, Sridhar Mani and Satyanarayana R. Pondugula
      Molecular Pharmacology March 2019, 95 (3) 324-334; DOI: https://doi.org/10.1124/mol.118.114587

  3. Chhour, Monivan

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  4. Christopoulos, Arthur

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

D

  1. Da Costa, Hervé

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  2. Desai, Aditya J.

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

  3. Ducrot, Pierre

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  4. Dupuis, Philippe

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  5. Dvorak, Zdenek

    1. Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression
      Kodye L. Abbott, Chloe S. Chaudhury, Aneesh Chandran, Saraswathi Vishveshwara, Zdenek Dvorak, Eva Jiskrova, Karolina Poulikova, Barbora Vyhlidalova, Sridhar Mani and Satyanarayana R. Pondugula
      Molecular Pharmacology March 2019, 95 (3) 324-334; DOI: https://doi.org/10.1124/mol.118.114587

E

  1. Endo, Kyoko

    1. Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca2+-Activated K+ Channel KCa3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Miki Matsui, Junko Kajikuri, Hiroaki Kito, Kyoko Endo, Yuki Hasegawa, Shinya Murate and Susumu Ohya
      Molecular Pharmacology March 2019, 95 (3) 294-302; DOI: https://doi.org/10.1124/mol.118.114405

F

  1. Ferry, Gilles

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  2. Fertig, Orlando

    1. Hyperforin-Induced Activation of the Pregnane X Receptor Is Influenced by the Organic Anion-Transporting Polypeptide 2B1
      Anima M. Schäfer, Olivier Potterat, Isabell Seibert, Orlando Fertig and Henriette E. Meyer zu Schwabedissen
      Molecular Pharmacology March 2019, 95 (3) 313-323; DOI: https://doi.org/10.1124/mol.118.114066

  3. Freissmuth, Michael

    1. Open Access
      Functional Selectivity and Partial Efficacy at the Monoamine Transporters: A Unified Model of Allosteric Modulation and Amphetamine-Induced Substrate Release
      Peter S. Hasenhuetl, Shreyas Bhat, Michael Freissmuth and Walter Sandtner
      Molecular Pharmacology March 2019, 95 (3) 303-312; DOI: https://doi.org/10.1124/mol.118.114793

G

  1. Gacsalyi, István

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  2. Giganti, Adeline

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  3. Goswami, Vishalgiri

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  4. Guedouari, Hala

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  5. Guillaumet, Gérald

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

H

  1. Hasegawa, Yuki

    1. Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca2+-Activated K+ Channel KCa3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Miki Matsui, Junko Kajikuri, Hiroaki Kito, Kyoko Endo, Yuki Hasegawa, Shinya Murate and Susumu Ohya
      Molecular Pharmacology March 2019, 95 (3) 294-302; DOI: https://doi.org/10.1124/mol.118.114405

  2. Hasenhuetl, Peter S.

    1. Open Access
      Functional Selectivity and Partial Efficacy at the Monoamine Transporters: A Unified Model of Allosteric Modulation and Amphetamine-Induced Substrate Release
      Peter S. Hasenhuetl, Shreyas Bhat, Michael Freissmuth and Walter Sandtner
      Molecular Pharmacology March 2019, 95 (3) 303-312; DOI: https://doi.org/10.1124/mol.118.114793

  3. Hirao-Suzuki, Masayo

    1. Repeated Exposure to 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an Active Metabolite of Bisphenol A, Aggressively Stimulates Breast Cancer Cell Growth in an Estrogen Receptor β (ERβ)–Dependent Manner
      Masayo Hirao-Suzuki, Shuso Takeda, Katsuhiro Okuda, Masufumi Takiguchi and Shin’ichi Yoshihara
      Molecular Pharmacology March 2019, 95 (3) 260-268; DOI: https://doi.org/10.1124/mol.118.114124

  4. Hirsch, Etienne C.

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

J

  1. Janda, Elzbieta

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  2. Jin, Whitney

    1. Structural Basis of p97 Inhibition by the Site-Selective Anticancer Compound CB-5083
      Wai Kwan Tang, Taivan Odzorig, Whitney Jin and Di Xia
      Molecular Pharmacology March 2019, 95 (3) 286-293; DOI: https://doi.org/10.1124/mol.118.114256

  3. Jiskrova, Eva

    1. Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression
      Kodye L. Abbott, Chloe S. Chaudhury, Aneesh Chandran, Saraswathi Vishveshwara, Zdenek Dvorak, Eva Jiskrova, Karolina Poulikova, Barbora Vyhlidalova, Sridhar Mani and Satyanarayana R. Pondugula
      Molecular Pharmacology March 2019, 95 (3) 324-334; DOI: https://doi.org/10.1124/mol.118.114587

K

  1. Kajikuri, Junko

    1. Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca2+-Activated K+ Channel KCa3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Miki Matsui, Junko Kajikuri, Hiroaki Kito, Kyoko Endo, Yuki Hasegawa, Shinya Murate and Susumu Ohya
      Molecular Pharmacology March 2019, 95 (3) 294-302; DOI: https://doi.org/10.1124/mol.118.114405

  2. Kane, Daniel A.

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  3. Kito, Hiroaki

    1. Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca2+-Activated K+ Channel KCa3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Miki Matsui, Junko Kajikuri, Hiroaki Kito, Kyoko Endo, Yuki Hasegawa, Shinya Murate and Susumu Ohya
      Molecular Pharmacology March 2019, 95 (3) 294-302; DOI: https://doi.org/10.1124/mol.118.114405

L

  1. Lam, Polo C. H.

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

  2. Le Diguarher, Thierry

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

M

  1. Mani, Sridhar

    1. Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression
      Kodye L. Abbott, Chloe S. Chaudhury, Aneesh Chandran, Saraswathi Vishveshwara, Zdenek Dvorak, Eva Jiskrova, Karolina Poulikova, Barbora Vyhlidalova, Sridhar Mani and Satyanarayana R. Pondugula
      Molecular Pharmacology March 2019, 95 (3) 324-334; DOI: https://doi.org/10.1124/mol.118.114587

  2. Matsui, Miki

    1. Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca2+-Activated K+ Channel KCa3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Miki Matsui, Junko Kajikuri, Hiroaki Kito, Kyoko Endo, Yuki Hasegawa, Shinya Murate and Susumu Ohya
      Molecular Pharmacology March 2019, 95 (3) 294-302; DOI: https://doi.org/10.1124/mol.118.114405

  3. Mechin, Ingrid

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

  4. Meyer zu Schwabedissen, Henriette E.

    1. Hyperforin-Induced Activation of the Pregnane X Receptor Is Influenced by the Organic Anion-Transporting Polypeptide 2B1
      Anima M. Schäfer, Olivier Potterat, Isabell Seibert, Orlando Fertig and Henriette E. Meyer zu Schwabedissen
      Molecular Pharmacology March 2019, 95 (3) 313-323; DOI: https://doi.org/10.1124/mol.118.114066

  5. Michel, Patrick P.

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  6. Miller, Laurence J.

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

  7. Munakata, Tatsuo

    1. Mexiletine Block of Voltage-Gated Sodium Channels: Isoform- and State-Dependent Drug–Pore Interactions
      Hiroki Nakagawa, Tatsuo Munakata and Akihiko Sunami
      Molecular Pharmacology March 2019, 95 (3) 236-244; DOI: https://doi.org/10.1124/mol.118.114025

  8. Murate, Shinya

    1. Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca2+-Activated K+ Channel KCa3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Miki Matsui, Junko Kajikuri, Hiroaki Kito, Kyoko Endo, Yuki Hasegawa, Shinya Murate and Susumu Ohya
      Molecular Pharmacology March 2019, 95 (3) 294-302; DOI: https://doi.org/10.1124/mol.118.114405

N

  1. Nagarajan, Karthigeyan

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

  2. Nair, Anil

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

  3. Nakagawa, Hiroki

    1. Mexiletine Block of Voltage-Gated Sodium Channels: Isoform- and State-Dependent Drug–Pore Interactions
      Hiroki Nakagawa, Tatsuo Munakata and Akihiko Sunami
      Molecular Pharmacology March 2019, 95 (3) 236-244; DOI: https://doi.org/10.1124/mol.118.114025

  4. Nepveu, Françoise

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

O

  1. Odzorig, Taivan

    1. Structural Basis of p97 Inhibition by the Site-Selective Anticancer Compound CB-5083
      Wai Kwan Tang, Taivan Odzorig, Whitney Jin and Di Xia
      Molecular Pharmacology March 2019, 95 (3) 286-293; DOI: https://doi.org/10.1124/mol.118.114256

  2. Ohya, Susumu

    1. Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca2+-Activated K+ Channel KCa3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells
      Miki Matsui, Junko Kajikuri, Hiroaki Kito, Kyoko Endo, Yuki Hasegawa, Shinya Murate and Susumu Ohya
      Molecular Pharmacology March 2019, 95 (3) 294-302; DOI: https://doi.org/10.1124/mol.118.114405

  3. Okuda, Katsuhiro

    1. Repeated Exposure to 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an Active Metabolite of Bisphenol A, Aggressively Stimulates Breast Cancer Cell Growth in an Estrogen Receptor β (ERβ)–Dependent Manner
      Masayo Hirao-Suzuki, Shuso Takeda, Katsuhiro Okuda, Masufumi Takiguchi and Shin’ichi Yoshihara
      Molecular Pharmacology March 2019, 95 (3) 260-268; DOI: https://doi.org/10.1124/mol.118.114124

  4. Orry, Andrew

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

P

  1. Patel, Aakash

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  2. Paysant, Jérôme

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  3. Pondugula, Satyanarayana R.

    1. Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression
      Kodye L. Abbott, Chloe S. Chaudhury, Aneesh Chandran, Saraswathi Vishveshwara, Zdenek Dvorak, Eva Jiskrova, Karolina Poulikova, Barbora Vyhlidalova, Sridhar Mani and Satyanarayana R. Pondugula
      Molecular Pharmacology March 2019, 95 (3) 324-334; DOI: https://doi.org/10.1124/mol.118.114587

  4. Potterat, Olivier

    1. Hyperforin-Induced Activation of the Pregnane X Receptor Is Influenced by the Organic Anion-Transporting Polypeptide 2B1
      Anima M. Schäfer, Olivier Potterat, Isabell Seibert, Orlando Fertig and Henriette E. Meyer zu Schwabedissen
      Molecular Pharmacology March 2019, 95 (3) 313-323; DOI: https://doi.org/10.1124/mol.118.114066

  5. Poulikova, Karolina

    1. Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression
      Kodye L. Abbott, Chloe S. Chaudhury, Aneesh Chandran, Saraswathi Vishveshwara, Zdenek Dvorak, Eva Jiskrova, Karolina Poulikova, Barbora Vyhlidalova, Sridhar Mani and Satyanarayana R. Pondugula
      Molecular Pharmacology March 2019, 95 (3) 324-334; DOI: https://doi.org/10.1124/mol.118.114587

R

  1. Reybier, Karine

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

S

  1. Sandtner, Walter

    1. Open Access
      Functional Selectivity and Partial Efficacy at the Monoamine Transporters: A Unified Model of Allosteric Modulation and Amphetamine-Induced Substrate Release
      Peter S. Hasenhuetl, Shreyas Bhat, Michael Freissmuth and Walter Sandtner
      Molecular Pharmacology March 2019, 95 (3) 303-312; DOI: https://doi.org/10.1124/mol.118.114793

  2. Schäfer, Anima M.

    1. Hyperforin-Induced Activation of the Pregnane X Receptor Is Influenced by the Organic Anion-Transporting Polypeptide 2B1
      Anima M. Schäfer, Olivier Potterat, Isabell Seibert, Orlando Fertig and Henriette E. Meyer zu Schwabedissen
      Molecular Pharmacology March 2019, 95 (3) 313-323; DOI: https://doi.org/10.1124/mol.118.114066

  3. Seibert, Isabell

    1. Hyperforin-Induced Activation of the Pregnane X Receptor Is Influenced by the Organic Anion-Transporting Polypeptide 2B1
      Anima M. Schäfer, Olivier Potterat, Isabell Seibert, Orlando Fertig and Henriette E. Meyer zu Schwabedissen
      Molecular Pharmacology March 2019, 95 (3) 313-323; DOI: https://doi.org/10.1124/mol.118.114066

  4. Sexton, Patrick M.

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

  5. Stojko, Johann

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  6. Sunami, Akihiko

    1. Mexiletine Block of Voltage-Gated Sodium Channels: Isoform- and State-Dependent Drug–Pore Interactions
      Hiroki Nakagawa, Tatsuo Munakata and Akihiko Sunami
      Molecular Pharmacology March 2019, 95 (3) 236-244; DOI: https://doi.org/10.1124/mol.118.114025

T

  1. Takeda, Shuso

    1. Repeated Exposure to 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an Active Metabolite of Bisphenol A, Aggressively Stimulates Breast Cancer Cell Growth in an Estrogen Receptor β (ERβ)–Dependent Manner
      Masayo Hirao-Suzuki, Shuso Takeda, Katsuhiro Okuda, Masufumi Takiguchi and Shin’ichi Yoshihara
      Molecular Pharmacology March 2019, 95 (3) 260-268; DOI: https://doi.org/10.1124/mol.118.114124

  2. Takiguchi, Masufumi

    1. Repeated Exposure to 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an Active Metabolite of Bisphenol A, Aggressively Stimulates Breast Cancer Cell Growth in an Estrogen Receptor β (ERβ)–Dependent Manner
      Masayo Hirao-Suzuki, Shuso Takeda, Katsuhiro Okuda, Masufumi Takiguchi and Shin’ichi Yoshihara
      Molecular Pharmacology March 2019, 95 (3) 260-268; DOI: https://doi.org/10.1124/mol.118.114124

  3. Tang, Wai Kwan

    1. Structural Basis of p97 Inhibition by the Site-Selective Anticancer Compound CB-5083
      Wai Kwan Tang, Taivan Odzorig, Whitney Jin and Di Xia
      Molecular Pharmacology March 2019, 95 (3) 286-293; DOI: https://doi.org/10.1124/mol.118.114256

V

  1. Valant, Celine

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

  2. Viaud-Massuard, Marie-Claude

    1. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization
      Jean A. Boutin, Frederic Bouillaud, Elzbieta Janda, István Gacsalyi, Gérald Guillaumet, Etienne C. Hirsch, Daniel A. Kane, Françoise Nepveu, Karine Reybier, Philippe Dupuis, Marc Bertrand, Monivan Chhour, Thierry Le Diguarher, Mathias Antoine, Karen Brebner, Hervé Da Costa, Pierre Ducrot, Adeline Giganti, Vishalgiri Goswami, Hala Guedouari, Patrick P. Michel, Aakash Patel, Jérôme Paysant, Johann Stojko, Marie-Claude Viaud-Massuard and Gilles Ferry
      Molecular Pharmacology March 2019, 95 (3) 269-285; DOI: https://doi.org/10.1124/mol.118.114231

  3. Vishveshwara, Saraswathi

    1. Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression
      Kodye L. Abbott, Chloe S. Chaudhury, Aneesh Chandran, Saraswathi Vishveshwara, Zdenek Dvorak, Eva Jiskrova, Karolina Poulikova, Barbora Vyhlidalova, Sridhar Mani and Satyanarayana R. Pondugula
      Molecular Pharmacology March 2019, 95 (3) 324-334; DOI: https://doi.org/10.1124/mol.118.114587

  4. Vyhlidalova, Barbora

    1. Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression
      Kodye L. Abbott, Chloe S. Chaudhury, Aneesh Chandran, Saraswathi Vishveshwara, Zdenek Dvorak, Eva Jiskrova, Karolina Poulikova, Barbora Vyhlidalova, Sridhar Mani and Satyanarayana R. Pondugula
      Molecular Pharmacology March 2019, 95 (3) 324-334; DOI: https://doi.org/10.1124/mol.118.114587

W

  1. Wootten, Denise

    1. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor
      Aditya J. Desai, Ingrid Mechin, Karthigeyan Nagarajan, Celine Valant, Denise Wootten, Polo C. H. Lam, Andrew Orry, Ruben Abagyan, Anil Nair, Patrick M. Sexton, Arthur Christopoulos and Laurence J. Miller
      Molecular Pharmacology March 2019, 95 (3) 245-259; DOI: https://doi.org/10.1124/mol.118.114082

X

  1. Xia, Di

    1. Structural Basis of p97 Inhibition by the Site-Selective Anticancer Compound CB-5083
      Wai Kwan Tang, Taivan Odzorig, Whitney Jin and Di Xia
      Molecular Pharmacology March 2019, 95 (3) 286-293; DOI: https://doi.org/10.1124/mol.118.114256

Y

  1. Yoshihara, Shin’ichi

    1. Repeated Exposure to 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an Active Metabolite of Bisphenol A, Aggressively Stimulates Breast Cancer Cell Growth in an Estrogen Receptor β (ERβ)–Dependent Manner
      Masayo Hirao-Suzuki, Shuso Takeda, Katsuhiro Okuda, Masufumi Takiguchi and Shin’ichi Yoshihara
      Molecular Pharmacology March 2019, 95 (3) 260-268; DOI: https://doi.org/10.1124/mol.118.114124
Back to top

In this issue

Advertisement